Skip to main content
Download PDF

Correction to: Short-term safety results from compassionate use of risdiplam in patients with spinal muscular atrophy in Germany

Orphanet Journal of Rare Diseases volume 17, Article number: 387 (2022) Cite this article

The Original Article was published on 19 July 2022

Correction to: Orphanet Journal of Rare Diseases (2022) 17:276 https://doi.org/10.1186/s13023-022-02420-8

Following publication of the original article [1], we have been notified that there is a typographical error in the Fig. 1 text. It should be as per below:

Figure 1: “111 patients received ≥ 1 risdiplam dose:”

Reference

  1. Hahn A, et al. Short-term safety results from compassionate use of risdiplam in patients with spinal muscular atrophy in Germany. Orphanet J Rare Dis. 2022;17:276. https://doi.org/10.1186/s13023-022-02420-8.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Child Neurology, University of Gießen, Giessen, Germany

    Andreas Hahn

  2. Department of Neurology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany

    René Günther

  3. Department of Neurology, University of Ulm, Ulm, Germany

    Albert Ludolph

  4. Department of Pediatric Neurology, Münster University Hospital, Münster, Germany

    Oliver Schwartz

  5. Division of Pediatric Neurology, Department of Pediatrics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany

    Regina Trollmann

  6. Department of Neurodegenerative Diseases and Gerontopsychiatry/Neurology, University of Bonn Medical Center, Bonn, Germany

    Patrick Weydt

  7. Department of Neurology, Heidelberg University Hospital, Heidelberg, Germany

    Markus Weiler

  8. Roche Pharma AG, Grenzach-Wyhlen, Germany

    Kathrin Neuland & Martin Sebastian Schwaderer

  9. Department of Neurology, University Hospital Essen, Essen, Germany

    Tim Hagenacker

Authors
  1. Andreas Hahn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. René Günther
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Albert Ludolph
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Oliver Schwartz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Regina Trollmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Patrick Weydt
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Markus Weiler
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Kathrin Neuland
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Martin Sebastian Schwaderer
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Tim Hagenacker
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

the Risdiplam Compassionate Use Program Group

Corresponding author

Correspondence to Tim Hagenacker.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hahn, A., Günther, R., Ludolph, A. et al. Correction to: Short-term safety results from compassionate use of risdiplam in patients with spinal muscular atrophy in Germany. Orphanet J Rare Dis 17, 387 (2022). https://doi.org/10.1186/s13023-022-02548-7

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13023-022-02548-7

Orphanet Journal of Rare Diseases

ISSN: 1750-1172